Last reviewed · How we verify
Talc Slurry
At a glance
| Generic name | Talc Slurry |
|---|---|
| Sponsor | The Cooper Health System |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Comparison of Talc Slurry Versus Talc Insufflation: A Study on Effectiveness, Safety, and Hospital Outcomes in Pleurodesis (NA)
- Intrapleural Fibrinolytic Therapy to Enhance Chemical Pleurodesis Enhance Chemical Pleurodesis (PHASE4)
- Stop Air Leak by Talc or Autologous Blood Patch Therapy (PHASE2, PHASE3)
- Out Patient Talc Slurry Via Indwelling Pleural Catheter for Malignant Pleural Effusion Vs Usual Inpatient Management (NA)
- Efficacy, Safety and Re-occurrence of Pneumothorax and Hydro-pneumothorax With Talc and Pyodine Pleurodesis (PHASE1, PHASE2)
- Talc Outpatient Pleurodesis With Indwelling Catheter (NA)
- Using Ultrasound to Predict the Results of Draining Pleural Effusions
- EDIT Management Feasibility Trial (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Talc Slurry CI brief — competitive landscape report
- Talc Slurry updates RSS · CI watch RSS
- The Cooper Health System portfolio CI